no, regeneron is a ten-bagger but you never could have gotten in on that gigantic gain if you didn'trisk in 2005 buying a company with no profits and only the promise of a ceo that things would work out. it worked out in a many way but many similar other ones have lost you norml he aenormous sum. that's okay. as long as you cast wide net if you take small positions in ten of these little biotech, nine of them have gone to zero as long as the tenth was regeneron you still would have made a monster gain. it should only be one small part of your portfolio but belongs there because the risk/reward absolutely makes sense when you're young for older investors, though, speculation is much more risky and only recommend playing it with excess cash that you absolutely can afford to lose. here's the bottom line remember to speculate while you're still young enough to be able to take the hit if something goes wrong as long as you're disciplined and only makes a small part of your discretionary portfolio not your retirement portfolio it's absolutely worth hunting for the next regeneron without he

they are the older dice folks but when they pay off, it is unbelievable i keep believing i look at regeneron how stalled it is, bia marine -- biomarine amgen has been a terrible performer. the big biotechs have been -- celgene, remember bristol-myers keeps going up i think bristol meyers is a stock to be owned. they are doing good things by the way, the cheapest drug stock alg. allergan there is a pill they have migraine sufferers as the folks for the american migraine foundation they have a pill for you a kite migraine there has never been a pill. you get a mieg dpran, boom you take the -- migraine, boom, you take a pill, the pain goes away. that's what they need to replace one of the biggest drugs ever. it's huge. >> one of the components of healthcare that did see some increases in inflation this month. >> yes >> obviously >> the democrats have never really been against biotech making the big money >> it was yellen >> yellen, she didn't like playing the biotechs again, elizabeth warren, there was a good piece today about senator warren in the journal about what our life would be like with